Bluebird Bio (NQ: BLUE )
2.860 -1.950 (-40.54%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
All News about Bluebird Bio
Long-Term Data Presented at ASH Support beti-cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
December 10, 2023
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.
Topics Artificial Intelligence
Exposures Artificial Intelligence